Reevaluation of reference values for bone marrow differential counts in 236 healthy bone marrow donors.


Journal

Annals of hematology
ISSN: 1432-0584
Titre abrégé: Ann Hematol
Pays: Germany
ID NLM: 9107334

Informations de publication

Date de publication:
Dec 2020
Historique:
received: 03 07 2020
accepted: 01 09 2020
pubmed: 17 9 2020
medline: 15 12 2020
entrez: 16 9 2020
Statut: ppublish

Résumé

Despite the increasing role of molecular markers, differential counts and morphology of hematopoietic cells in the bone marrow (BM) remain essential diagnostic criteria in hematological diseases. However, the respective reference values for BM myelogram commonly used came from small series with limited numbers of healthy individuals. We evaluated the myelograms of 236 healthy individuals who underwent unrelated bone marrow donation. Health check-ups were performed 4 weeks prior to harvest. Samples for this study, taken from the first aspiration, were stained according to the standard Pappenheim method. Three experienced investigators assessed cellularity, megakaryopoiesis, and differential counts independently. The median donor age was 31 (range 18-51) years. Predonation tests did not reveal any relevant morbidity. Thirty-seven out of 42 hypocellular marrow samples were from younger donors up to 39 years. Content of megakaryocytes was normal in 210 specimens (89%). Gender and body mass index had significant impact on hematopoiesis, whereas age had not. The number of erythroblasts was higher (about 32%) and the proportion granulopoiesis slightly lower (about 50%) compared with previous studies. Differential counts showed also some differences with respect to individual maturation stages in these lines. Interrater comparisons showed greater reliability for the assignment of cells to the different hematopoietic cell lines than for single-cell diagnoses. This study largely confirms the results for cell counts in normal human bone marrow available from previous reports and provides some insights into factors that affect individual cell populations. It also reveals substantial variability among even experienced investigators in cytological diagnoses.

Identifiants

pubmed: 32935189
doi: 10.1007/s00277-020-04255-4
pii: 10.1007/s00277-020-04255-4
pmc: PMC7683448
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2723-2729

Références

Arch Intern Med. 1998 Sep 14;158(16):1789-95
pubmed: 9738608
Br J Haematol. 1996 Jul;94(1):206-9
pubmed: 8757536
Int J Lab Hematol. 2008 Oct;30(5):349-64
pubmed: 18822060
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2013 May;56(5-6):809-13
pubmed: 23703502
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2013 May;56(5-6):802-8
pubmed: 23703501
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2013 May;56(5-6):698-706
pubmed: 23703488
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2013 May;56(5-6):765-71
pubmed: 23703496

Auteurs

Stefani Parmentier (S)

Department of Hematology, Oncology and Palliative Care, Rems-Murr-Hospital, Winnenden, Germany.

Michael Kramer (M)

Medical Department I, University Hospital Dresden, Fetscherstr. 74, 01307, Dresden, Germany.

Swetlana Weller (S)

Medical Department I, University Hospital Dresden, Fetscherstr. 74, 01307, Dresden, Germany.

Ulrich Schuler (U)

Medical Department I, University Hospital Dresden, Fetscherstr. 74, 01307, Dresden, Germany.

Rainer Ordemann (R)

Medical Department I, University Hospital Dresden, Fetscherstr. 74, 01307, Dresden, Germany.

Gabi Rall (G)

DKMS German Bone Marrow Donor Center, Tübingen, Germany.

Markus Schaich (M)

Department of Hematology, Oncology and Palliative Care, Rems-Murr-Hospital, Winnenden, Germany.

Martin Bornhäuser (M)

Medical Department I, University Hospital Dresden, Fetscherstr. 74, 01307, Dresden, Germany.

Gerhard Ehninger (G)

Medical Department I, University Hospital Dresden, Fetscherstr. 74, 01307, Dresden, Germany.

Frank Kroschinsky (F)

Medical Department I, University Hospital Dresden, Fetscherstr. 74, 01307, Dresden, Germany. frank.kroschinsky@ukdd.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH